Avivagen VIVXF Stock
Avivagen Price Chart
Avivagen VIVXF Financial and Trading Overview
| Avivagen stock price | 0.0001 USD |
| Previous Close | 0.01 USD |
| Open | 0.01 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.01 - 0.01 USD |
| 52 Week Range | 0.0082 - 0.15 USD |
| Volume | 3K USD |
| Avg. Volume | 2.29K USD |
| Market Cap | 776.95K USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
VIVXF Valuation Measures
| Enterprise Value | 7.91M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.0741698 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 10.934 |
| Enterprise Value/EBITDA | -2.013 |
Trading Information
Avivagen Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -92.96% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.15 USD |
| 52 Week Low | 0.0082 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.06 USD |
VIVXF Share Statistics
| Avg. Volume (3 month) | 2.29K USD |
| Avg. Daily Volume (10-Days) | 3.41K USD |
| Shares Outstanding | 77.69M |
| Float | 76.27M |
| Short Ratio | N/A |
| % Held by Insiders | 1.11% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | October 31, 2022 |
| Most Recent Quarter (mrq) | April 30, 2023 |
| Next Fiscal Year End | October 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -547.58% |
| Gross Margin | 41.96% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -148.30% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 723.3K USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | -12.19% |
| Gross Profit (ttm) | 400.3K USD |
| EBITDA | -3929382 USD |
| Net Income Avi to Common (ttm) | -5608436 USD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 17.19K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 6.77M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.036 |
| Book Value Per Share (mrq) | -0.107 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1953590 USD |
| Levered Free Cash Flow (ttm) | -995128 USD |
Profile of Avivagen
| Country | United States |
| State | ON |
| City | Ottawa |
| Address | 100 Sussex Drive |
| ZIP | K1A 0R6 |
| Phone | N/A |
| Website | https://www.avivagen.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.
Q&A For Avivagen Stock
What is a current VIVXF stock price?
Avivagen VIVXF stock price today per share is 0.0001 USD.
How to purchase Avivagen stock?
You can buy VIVXF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Avivagen?
The stock symbol or ticker of Avivagen is VIVXF.
Which industry does the Avivagen company belong to?
The Avivagen industry is Drug Manufacturers-Specialty & Generic.
How many shares does Avivagen have in circulation?
The max supply of Avivagen shares is 77.69M.
What is Avivagen Price to Earnings Ratio (PE Ratio)?
Avivagen PE Ratio is now.
What was Avivagen earnings per share over the trailing 12 months (TTM)?
Avivagen EPS is -0.04 USD over the trailing 12 months.
Which sector does the Avivagen company belong to?
The Avivagen sector is Healthcare.